1. Home
  2. SHOO vs FOLD Comparison

SHOO vs FOLD Comparison

Compare SHOO & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SHOO
  • FOLD
  • Stock Information
  • Founded
  • SHOO 1990
  • FOLD 2002
  • Country
  • SHOO United States
  • FOLD United States
  • Employees
  • SHOO N/A
  • FOLD N/A
  • Industry
  • SHOO Shoe Manufacturing
  • FOLD Biotechnology: Pharmaceutical Preparations
  • Sector
  • SHOO Consumer Discretionary
  • FOLD Health Care
  • Exchange
  • SHOO Nasdaq
  • FOLD Nasdaq
  • Market Cap
  • SHOO 3.1B
  • FOLD 3.5B
  • IPO Year
  • SHOO 1993
  • FOLD 2007
  • Fundamental
  • Price
  • SHOO $43.23
  • FOLD $9.68
  • Analyst Decision
  • SHOO Hold
  • FOLD Strong Buy
  • Analyst Count
  • SHOO 8
  • FOLD 8
  • Target Price
  • SHOO $45.38
  • FOLD $17.57
  • AVG Volume (30 Days)
  • SHOO 816.2K
  • FOLD 2.6M
  • Earning Date
  • SHOO 11-07-2024
  • FOLD 11-06-2024
  • Dividend Yield
  • SHOO 1.94%
  • FOLD N/A
  • EPS Growth
  • SHOO 6.16
  • FOLD N/A
  • EPS
  • SHOO 2.36
  • FOLD N/A
  • Revenue
  • SHOO $2,220,323,000.00
  • FOLD $493,671,000.00
  • Revenue This Year
  • SHOO $15.16
  • FOLD $33.97
  • Revenue Next Year
  • SHOO $5.30
  • FOLD $21.74
  • P/E Ratio
  • SHOO $18.35
  • FOLD N/A
  • Revenue Growth
  • SHOO 14.89
  • FOLD 32.58
  • 52 Week Low
  • SHOO $36.23
  • FOLD $9.02
  • 52 Week High
  • SHOO $50.01
  • FOLD $14.57
  • Technical
  • Relative Strength Index (RSI)
  • SHOO 35.28
  • FOLD 29.07
  • Support Level
  • SHOO $43.18
  • FOLD $10.73
  • Resistance Level
  • SHOO $45.51
  • FOLD $11.36
  • Average True Range (ATR)
  • SHOO 1.38
  • FOLD 0.48
  • MACD
  • SHOO -0.14
  • FOLD -0.20
  • Stochastic Oscillator
  • SHOO 2.59
  • FOLD 1.49

About SHOO Steven Madden Ltd.

Steven Madden Ltd designs and sells brand-name and private-label footwear and accessories. Its products are geared toward fashion-conscious adults and children. The company sells its products through department stores and other retailers as well as its own stores and websites. The company's revenue comes from its operating segments: Wholesale Footwear, Wholesale Accessories or Apparel, Direct-to-Consumer, and Licensing. The wholesale footwear segment accounts for the majority of revenue.

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.

Share on Social Networks: